Home City Therapeutics

City Therapeutics

In operation
Series B
RNAi Drug Developer
Basic
Enterprise Profile
LinkedIn

Basic Information

City Therapeutics is a biopharmaceutical company leveraging next-generation small interfering RNA (siRNA) engineering to enhance and expand the application scope of RNAi-based drugs. The company is building an innovative pipeline of RNAi therapies to make a significant impact on patients across multiple therapeutic areas.
City Therapeutics, Inc.
Cambridge,Massachusetts,United States of America
15~50 people
January 01, 2024
info@citytx.com

Enterprise Profile

Industrial Sector
New Drug Development Gene Therapy Biological Drug Production
Technology
Gene Technology Biotechnology
Concept
Therapeutic Products
Application Scenarios
Innovative Drugs